Skip to search formSkip to main contentSkip to account menu

leridistim

Known as: 14-125 interleukin-3(14-alanine, 50-aspartic acid), granulocyte colony stimulating factor(17-serine) fusion protein, MPO, Myelopoietin 
A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
In recent years, a deeper understanding of the pathobiology of atherothrombosis as the underlying mechanism of acute coronary… 
2002
2002
The use of growth factors (GFs) in the treatment of radiation injury has focused on enhancing recovery from acute radiation… 
2002
2002
The in vitro activity of leridistim was characterized for cell proliferation, generation of colony-forming units (CFU) and… 
2001
2001
Myelopoietins comprise a class of chimeric cytokine receptor agonists consisting of an hIL-3 (human interleukin-3) receptor… 
Review
2000
Review
2000
The shared properties of haematopoietic cytokines and their receptors have enabled the genetically engineered construction of… 
1999
1999
Myelopoietins (MPOs) are a family of engineered dual interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF…